Application of traditional Chinese drugs in comprehensive treatment of primary liver cancer.
The present paper is a summary for treating 50 cases of Stage II primary liver cancer by the Integrated method of traditional Chinese and Western medicine. It was found by comparative observation that the average survival time of the Spleen-Deficiency (SD) type patients was markedly longer than that of Phlegm-Dampness-Stagnancy (PDS), Qi- and Blood-Stagnancy (QBS) and Liver-Kidney-Yin-Deficiency (LKYD) types, indicating that the SD type patients might have a better prognosis, and that the Chinese herbal medicine was an alternative for treating intermediate and late carcinoma.
Liu
F
F
Oncological Hospital, Shanghai Medical University.
D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000532:radiotherapy; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000627:therapeutic use; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D008516:Medicine, Chinese Traditional; D013852:Thiotepa / Q000627:therapeutic use
D003037:Cobalt Radioisotopes; D004365:Drugs, Chinese Herbal; D004317:Doxorubicin; D013852:Thiotepa; D005472:Fluorouracil